C4's Partnership with Roche, Gilead Options Kymera degrader, and Astellas Licenses Dyno Capsid
Plus the initial dosing of Enanta and Avencell's Clinical Trials
All About Watertown's VC Funding
2025 Funding numbers are in, 2026 early raises, Lyra Therapeutics runs out of time and more